Where AI helps a preclinical CRO: the quotes, protocols and reports around the bench work

A biotech sends a request on a Tuesday asking for twelve compounds in a kinase panel at two concentrations, dose response on the hits and a cell viability assay in three lines. Before any plate is run, someone at the contract research organization has to work out which assays match the request, how much of each compound to ask for, what turnaround is realistic against current capacity and what to charge. Then come the protocol, the compound intake manifest, the study schedule and, weeks later, a report that has to be checked line by line against the raw data.

Much of this work falls to PhD scientists and study directors, because they understand the assays. It is skilled work, but it is also repetitive, and it competes directly with time spent on the science clients are paying for. The most dependable AI gains at a preclinical CRO come from preparing these documents, and far fewer come from trying to automate scientific judgment.

The quote is the first bottleneck

Requests rarely arrive in a standard form. Some come through a web form, many come as emails with a spreadsheet of compound IDs, and some refer to a previous study by number. Turning that into a quote means mapping the client's language onto the assay catalog, checking for special conditions such as a non-standard ATP concentration or a specific cell line, and applying the right pricing for volume and turnaround.

An agent can produce the first draft of that mapping. It reads the request, identifies the assays and conditions, flags anything it cannot match to the catalog and assembles a quote in the CRO's own format for a business development manager or scientist to review. Response time to a request for quote matters in a competitive market, and cutting it from days to hours is often the improvement a client notices first.

Protocols and manifests are template work with high stakes

Most study protocols are variations on validated templates. The variation is where errors creep in, such as a concentration range copied from the previous client, a cell line name that does not match the cell bank record or a compound count that differs from the manifest. An agent that drafts the protocol from the approved template and the confirmed quote, and cross-checks every compound, quantity and condition against the manifest and the LIMS, removes a class of mistakes that are expensive to discover after plates are run.

For studies conducted under Good Laboratory Practice, the requirements around protocol approval, amendments and audit trails stay exactly as they were when a draft comes from software. The draft still goes through the same sign-off, and the system keeps a record of what it generated and what the study director changed. That record tends to make quality assurance reviews easier, since every change can be traced.

Reports are where the hours pile up

A final report combines methods, results tables, curve fits, figures and interpretation, and every number in it has to match the processed data. Assembling the methods section from the protocol, building results tables directly from the analysis output and drafting a plain description of the findings are tasks an agent handles reliably when it works from the lab's structured data. The scientist's time moves to reviewing interpretation and handling exceptions, such as a compound that precipitated or a plate that failed QC and was rerun.

The same structured output can go to the client directly. Many sponsors would rather receive results as a clean data file mapped to their own compound IDs than as a PDF they have to re-key, and a CRO that offers both makes its data easier to use inside the sponsor's models.

What should stay with people

Assay selection for an unusual request, interpretation of an unexpected result and anything that changes the scientific design of a study belong with scientists. So does the final price on non-standard work. The agent's job is to have everything prepared and checked by the time the scientist reaches the decision, and to say clearly what it could not resolve. A CRO that sets those boundaries at the start finds adoption easier, because staff can see the system takes the drafting and leaves the judgment with them.

Starting small

The quote workflow is usually the best first project because it is self-contained and its value shows up in turnaround time within weeks. QueryNow has delivered more than 200 AI deployments, including work for pharmaceutical companies, and builds these agents inside the client's own environment and systems. Tell us the workflow you want gone, we build it in your environment in two weeks, and you pay $10,000 only after it meets the acceptance criteria you signed off on. Start at /build.